Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Blood Levels of GSK3915393 Administered to Healthy Participants of Chinese, Japanese and European Ancestry and to Assess Effects of GSK3915393 on Nintedanib [Phase 1]

View source ↗

Summary

A Phase 1 study assessing safety, tolerability, and blood levels of GSK3915393 in healthy participants of Chinese, Japanese, and European ancestry, and evaluati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• GSK3915393
• Nintedanib (nintedanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: COMPLETED